COVID-19 Records

roc mpox sequencing

2 messages over 3 days, 2024-04-22 – 2024-04-25.

  1. 2024-04-22 11:49 Yinda Kwe Claude open PDF p.16
    Hi , I hope this email finds you well. We just returned from the Congo with DNA from MPOX positive samples, and we're eager to perform full genome sequencing on these samples. Our aim is to address critical epidemiological questions surrounding the ongoing MPOX outbreak in Africa. We have a total of 35 samples with ct values ranging from 15 to 36. Given the direct impact this sequencing will have on the ongoing outbreak response, we would greatly appreciate it if you could prioritize this. Please let us know your thoughts. Best regards, Kwe From: NIAID RTB TAS Team <i @mail.nih.gov> 1o: SE oh gov Subject: GRS.24-04-25.0135: Your Request has been Submitted Date: Thu, 25 Apr 2024 13:25:45 -0400 L_NIAID RTB Header GRS.24-04-25.0135 Your Request has been Submitted Genomics Research Dear Claude Yinda, Thank you for submitting your request on 04/25/2024 at 1:25 PM EDT via the RTB Technology Accessioning System. Below are details of the request: Request ID: GRS.24-04-25.0135 Status: Pending Requested By: Claude Yinda Kwe SR 2b. g0v [+1 I Institute: National Institute of Allergy and Infectious Diseases Sectiot nomics Research Description: N/A Files Uploaded: = ROC-Mpox_GRS Sample Manifest Template.xisx Project Name: Republic of the Congo (ROC) Mpox sequencing Project Summary: We want to obtain the full genome sequences of mpox DNA from ROC. patients following an unprecedented outbreak in the neighboring Democratic Republic of the Congo (DRC) which seems to spillover into ROC. Data Analysis: - Consensus sequences - Sequencing depth maps Organism: Other Other Organism: mpox virus Experiment Type: Viral Genome If experiment includes Feature Barcodes or Hash Tags, send sequences to HE @viaia.nin.gov: No Number Of Samples: 35 Sample Type: DNA Delivery ETA: 4/24/2024 Would you like the original samples or any derivaties returned to you? If not, all material will be disposed of after 6 months: Yes Do these samples contain or were derived from a select agent?: Yes Are these samples derived from human patients and do you have IRB approval for sequencing?: Yes Would you like RTB (IDSS) to perform data analysi CAN: 8010044 Yes To view the status of this request at any time, please visit: Section Contact RTB Contact Technical Support Contact a Ona nc BE 2 cov BO 'Sign up for govDELIVERY messages. © 2023 NIH RTB. All Rights Reserved.
  2. 2024-04-25 13:27 Yinda Kwe Claude open PDF p.16
    Hi , I didn't hear from you concerning this. Cheers, Kwe